Skip to main content
SpringerLink
Log in

Polyester-Poly(Ethylene Glycol) Nanoparticles Loaded with the Pure Antiestrogen RU 58668: Physicochemical and Opsonization Properties

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The pure antiestrogen RU58668 (RU) was encapsulated within nanospheres (NS) and nanocapsules (NC) prepared from different polyester copolymers with poly(ethylene glycol) (PEG) chains. The influence of their physicochemical properties on drug release in vitro and their susceptibility to opsonization were evaluated.

Methods. RU-loaded PEG-bearing nanoparticles (NP) prepared by interfacial deposition of preformed polymer were characterized (size, zeta potential, percentage encapsulation and loading). In vitro release kinetics were studied in the presence of 10% fetal calf serum (FCS). Their opsonization in mouse serum was evaluated by silver staining of SDS-PAGE and Western blotting of desorbed proteins.

Results. The NS were smaller than NC and had a zeta potential close to zero and a higher percentage of loading. RU release from NS in vitro was reduced as compared with the dissolution profile of free RU in a serum-containing medium. Decreased opsonin adsorption at the surface of pegylated NS was observed.

Conclusion. Small nanoparticulate systems containing a high load of pure antiestrogen, showing reduced drug release, have been developed. Among the six nanosphere preparations containing RU, two show a size below 200 nm, and two others undergo reduced protein adsorption in the presence of serum, compatible with increased persistence in the blood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. J. I. MacGregor and V. C. Jordan. Basic guide to the mechanisms of anti-estrogen action. Pharmacol. Rev. 50:151–196 (1998).

    Google Scholar 

  2. P. Van de Velde, F. Nique, F. Bouchoux, J. Bremaud, M. C. Hameau, D. Lucas, C. Moratille, S. Viet, D. Philibert, and G. Teutsch. RU 58,668, a new pure anti-estrogen inducing a regression of human mammary carcinoma implanted in nude mice. J. Steroid Biochem. Mol. Biol. 48:187–196 (1994).

    Google Scholar 

  3. P. Van de Velde, F. Nique, J. Bremaud, M. C. Hameau, D. Philibert, and G. Teutsch. Exploration of the therapeutic potential of the anti-estrogen RU 58668 in breast cancer treatment. Ann. NY Acad. Sci. 761:164–175 (1995).

    Google Scholar 

  4. P. Van de Velde, F. Nique, P. Planchon, G. Prevost, J. Bremaud, M. C. Hameau, V. Magnien, D. Philibert, and G. Teutsch. RU 58668: further in vitro and in vivo pharmacological data related to its antitumoral activity. J. Steroid Biochem. Mol. Biol. 59:449–457 (1996).

    Google Scholar 

  5. S. M. Moghimi, A. C. Hunter, and J. C. Murray. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53:283–318 (2001).

    Google Scholar 

  6. M. Vittaz, D. Bazile, G. Spenlehauer, T. Verrecchia, M. Veillard, F. Puisieux, and D. Labarre. Effect of PEO surface density on long-circulating PLA–PEO nanoparticles which are very low complement activators. Biomaterials 17:1575–1581 (1996).

    Google Scholar 

  7. A. Gabizon and F. Martin. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs 54:15–21 (1997).

    Google Scholar 

  8. P. Quellec, R. Gref, L. Perrin, E. Dellacherie, F. Sommer, J. M. Verbavatz, and M. J. Alonso. Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization. J. Biomed. Mater. Res. 42:45–54 (1998).

    Google Scholar 

  9. R. Gref, Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer. Biodegradable long-circulating polymeric nanospheres. Science 263:1600–1603 (1994).

    Google Scholar 

  10. R. Gref, A. Domb, P. Quellec, T. Blunk, R. H. Müller, J. M. Verbavatz, and R. Langer. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev. 16:215–233 (1995).

    Google Scholar 

  11. H. Fessi, F. Puisieux, J. Devissaguet, N. Ammoury, and S. Benita. Nanocapsules formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55:r1-r4 (1989).

    Google Scholar 

  12. W. Schaffner and C. Weissmann. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56:502–514 (1973).

    Google Scholar 

  13. V. C. Mosqueira, P. Legrand, A. Gulik, O. Bourdon, R. Gref, D. Labarre, and G. Barratt. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 22:2967–2979 (2001).

    Google Scholar 

  14. S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 95:4607–4612 (1998).

    Google Scholar 

  15. A. Nagayasu, K. Uchiyama, and H. Kiwada. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Deliv. Rev. 40:75–87 (1999).

    Google Scholar 

  16. M. Leroueil-Le Verger, L. Fluckiger, Y. I. Kim, M. Hoffman, and P. Maincent. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm. 46:137–143 (1998).

    Google Scholar 

  17. Y. Li, Y. Pei, X. Zhang, Z. Gu, Z. Zhou, W. Yuan, J. Zhou, J. Zhu and X. Gao. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J. Control. Release 71:203–211 (2001).

    Google Scholar 

  18. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, A. G. Karydas' and D. S. Ithakissios. PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 79:123–135 (2002).

    Google Scholar 

  19. T. Govender, T. Riley, T. Ehtezazi, M. C. Garnett, S. Stolnik, L. Illum, and S. S. Davis. Defining the drug incorporation properties of PLA-PEG nanoparticles. Int. J. Pharm. 199:95–110 (2000).

    Google Scholar 

  20. I. Brigger, P. Chaminade, V. Marsaud, M. Appel, M. Besnard, R. Gurny, M. Renoir, and P. Couvreur. Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new anti-estrogen formulation. Int. J. Pharm. 214:37–42 (2001).

    Google Scholar 

  21. J. Matsumoto, Y. Nakada, K. Sakurai, T. Nakamura, and Y. Takahashi. Preparation of nanoparticles consisted of poly(L-lactide)–poly(ethylene glycol)–poly(L-lactide) and their evaluation in vitro. Int. J. Pharm. 185:93–101 (1999).

    Google Scholar 

  22. R. Gref, P. Quellec, A. Sanchez, P. Calvo, E. Dellacherie, and M. J. Alonso. Development and characterization of CyA-loaded poly(lactic acid)–poly(ethylene glycol)PEG micro-and nanoparticles. Comparison with conventional PLA particulate carriers. Eur. J. Pharm. Biopharm. 51:111–118 (2001).

    Google Scholar 

  23. H. M. Redhead, S. S. Davis, and L. Illum. Drug delivery in poly(lactide–co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release 70:353–363 (2001).

    Google Scholar 

  24. V. Mosqueira, P. Legrand, R. Gref, and G. Barratt. In-vitro release kinetic studies of PEG-modified nanocapsules and nanospheres loaded with a lipophilic drug: halofantrine base. Proc. 26 Int. Symp. Control. Release Bioactive Mater. 26:1074–1075 (1999).

    Google Scholar 

  25. M. Polakovic, T. Gorner, R. Gref, and E. Dellacherie. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J. Control. Release 60:169–177 (1999).

    Google Scholar 

  26. A. L. Klibanov, K. Maruyama, V. P. Torchilin, and L. Huang. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:235–237 (1990).

    Google Scholar 

  27. R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R. H. Muller. "Stealth" corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf. B Biointerfaces 18:301–313 (2000).

    Google Scholar 

  28. U. Gaur, S. K. Sahoo, T. K. De, P. C. Ghosh, A. Maitra, and P. K. Ghosh. Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system. Int. J. Pharm. 202:1–10 (2000).

    Google Scholar 

  29. K. Ogawara, K. Furumoto, Y. Takakura, M. Hashida, K. Higaki, and T. Kimura. Surface hydrophobicity of particles is not necessarily the most important determinant in their in vivo disposition after intravenous administration in rats. J. Control. Release 77:191–198 (2001).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacologie Cellulaire et Moléculaire, UMR CNRS 8612, 92296, Châtenay-Malabry, France

    Thibault Ameller, Véronique Marsaud, Philippe Legrand, Ruxandra Gref, Gillian Barratt & Jack-Michel Renoir

Authors
  1. Thibault Ameller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Véronique Marsaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philippe Legrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruxandra Gref
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gillian Barratt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jack-Michel Renoir
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ameller, T., Marsaud, V., Legrand, P. et al. Polyester-Poly(Ethylene Glycol) Nanoparticles Loaded with the Pure Antiestrogen RU 58668: Physicochemical and Opsonization Properties. Pharm Res 20, 1063–1070 (2003). https://doi.org/10.1023/A:1024418524688

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024418524688

Search

Navigation